Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Bayer launches allergy control nasal spray Clarinaze in pharmacies

Manufacturer Bayer has launched Clarinaze nasal spray for allergy relief exclusively in pharmacies.

Launched in February, the daily-use spray follows the reclassification of Nasonex, from prescription-only medicine to a pharmacy medicine in 2017.

Clarinaze is the only product containing mometasone that is available without a prescription, Bayer claimed.

The spray is designed to prevent and relieve symptoms of allergies, such as sneezing and an itchy nose, the manufacturer said.

It takes between 12 and 48 hours to work and can be used up to two days before the start of the pollen season, Bayer continued.

The launch is being supported by a £1 million marketing campaign that includes training for pharmacy staff, it said.

One 18g Clarinaze pump spray retails at £13.99.  

To order, contact your wholesaler.

Do you stock many Bayer products?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005787

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel